Clinical Cardiology

• 

  Publication Venue For

  • Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Prior Bioprosthetic Valve Replacement or Valve Repair: Insights from the ARISTOTLE Trial. 2019
  • Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network Registry..  42:352-357. 2019
  • Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure..  42:277-284. 2019
  • Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes..  42:256-263. 2019
  • Endovascular treatment of femoro-popliteal lesions..  42:175-183. 2019
  • Platelet inhibition to target reperfusion injury trial: Rationale and study design..  42:5-12. 2019
  • Baseline atrial fibrillation is associated with contrast-induced nephropathy after cardiac catheterization in coronary artery disease: Systemic review and meta-analysis..  41:1555-1562. 2018
  • The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes..  41:1225-1231. 2018
  • The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes..  41:1259-1267. 2018
  • Atrial fibrillation in an African-American cohort: The Jackson Heart Study..  41:1049-1054. 2018
  • Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF..  41:945-952. 2018
  • A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study..  41:903-909. 2018
  • Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry..  41:758-768. 2018
  • Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials..  41:137-143. 2018
  • Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial..  41:39-45. 2018
  • Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study..  40:1197-1204. 2017
  • Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial..  40:946-954. 2017
  • Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort..  40:899-906. 2017
  • Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation..  40:746-751. 2017
  • Management of newly treated diabetes in Medicare beneficiaries with and without heart failure..  40:38-45. 2017
  • Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease..  39:721-727. 2016
  • Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program..  39:578-584. 2016
  • Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR..  39:585-595. 2016
  • Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome..  39:507-515. 2016
  • Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial..  39:497-506. 2016
  • Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial..  39:329-337. 2016
  • Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry..  39:119-125. 2016
  • The Association of Transfer Rate From Hospitals Without Revascularization Capabilities and Mortality Risk for Older Non-ST-Segment Elevation Myocardial Infarction Patients..  38:733-739. 2015
  • The Contemporary Use of Angiography and Revascularization Among Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Compared With South Korea.  38:708-714. 2015
  • The Contemporary Use of Angiography and Revascularization Among Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Compared With South Korea..  38:708-714. 2015
  • Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial Infarction.  38:455-461. 2015
  • Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial Infarction..  38:455-461. 2015
  • Comparative Effectiveness of Medical Therapy, Supervised Exercise, and Revascularization for Patients With Intermittent Claudication: A Network Meta-analysis..  38:378-386. 2015
  • Prognostic implications of low level cardiac troponin elevation using high-sensitivity cardiac troponin T..  38:230-235. 2015
  • Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure..  38:106-113. 2015
  • Characterizing major bleeding in patients with nonvalvular atrial fibrillation: A pharmacovigilance study of 27 467 patients taking Rivaroxaban.  38:63-68. 2015
  • Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban..  38:63-68. 2015
  • The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: Observations from the CRISPAMI trial.  38:25-31. 2015
  • The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial..  38:25-31. 2015
  • Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis..  37:337-342. 2014
  • A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States..  37:312-321. 2014
  • Authors' Reply.  37:323-323. 2014
  • Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD..  37:285-292. 2014
  • Doppler-detected valve movement in aortic stenosis: a predictor of adverse outcome..  37:167-171. 2014
  • A reevaluation of the costs of heart failure and its implications for allocation of health resources in the united states.  37:312-321. 2014
  • Combined Use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.  37:152-159. 2014
  • Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: A propensity-matched study.  37:14-20. 2014
  • Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis.  37:337-342. 2014
  • Doppler-detected valve movement in aortic stenosis: A predictor of adverse outcome.  37:167-171. 2014
  • Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: Insights from the society of thoracic surgeons CAPS-Care atrial fibrillation registry.  37:7-13. 2014
  • Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry..  37:7-13. 2014
  • Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD 2014
  • Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-cad.  37:285-292. 2014
  • Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: Findings from the ADHERE registry linked to medicare claims.  36:757-765. 2013
  • Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: Findings from the REACH registry.  36:721-727. 2013
  • Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: Findings from get with the guidelines-coronary artery disease.  36:749-756. 2013
  • Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease..  36:749-756. 2013
  • Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function..  36:611-620. 2013
  • Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.  36:611-620. 2013
  • Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: A propensity-matched study 2013
  • Predictors of Long-term Adherence to Evidence-based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry 2013
  • Relation Between Time of Symptom Onset of ST-Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry 2013
  • Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: From the national cardiovascular data registry.  36:222-227. 2013
  • Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease..  35:632-640. 2012
  • Increasing proportion of clinical trials using noninferiority end points..  35:522-523. 2012
  • Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program..  35:541-547. 2012
  • Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines..  35:424-429. 2012
  • Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines..  35:396-403. 2012
  • Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims..  34:682-688. 2011
  • Influence of clinical trial participation on subsequent antithrombin use..  33:E49-E55. 2010
  • Gender differences in the treatment of non-ST-segment elevation myocardial infarction.  33:99-103. 2010
  • Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care..  32:519-525. 2009
  • Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome..  32:E22-E28. 2009
  • The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE..  32:498-505. 2009
  • Prehospital electrocardiograms (ECGs) do not improve the process of emergency department care in hospitals with higher usage of ECGs in non-ST-segment elevation myocardial infarction patients.  32:668-674. 2009
  • Impact of anemia on physical function and survival among patients with coronary artery disease..  31:546-550. 2008
  • Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes..  31:I2-I9. 2008
  • Antiplatelet therapy and platelet function testing. Introduction..  31:I1. 2008
  • Assessing the current role of platelet function testing..  31:I10-I16. 2008
  • Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention..  31:I28-I35. 2008
  • Investigating the mechanisms of hyporesponse to antiplatelet approaches..  31:I21-I27. 2008
  • Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease..  31:125-129. 2008
  • The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention..  31:I17-I20. 2008
  • The Challenge of Defining Bleeding Among Patients with Acute Coronary Syndromes.  30:II16-II23. 2007
  • The challenge of defining bleeding among patients with acute coronary syndromes..  30:II16-II23. 2007
  • The burden of angina pectoris and its complications [corrected]..  30:I10-I15. 2007
  • The cardiovascular patient's perceptions of complementary and alternative medicine..  29:161-164. 2006
  • The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography..  28:333-336. 2005
  • Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial..  28:238-242. 2005
  • Conclusion.  25. 2002
  • Introduction: Redefining acute coronary syndrome care in the era of aggressive revascularization.  25. 2002
  • Matching resources to treatment decisions for patients with acute coronary syndromes.  25. 2002
  • Matching resources to treatment decisions for patients with acute coronary syndromes..  25:I2-I8. 2002
  • A case of severe ischemia-induced QT prolongation..  24:750. 2001
  • A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study.  22. 1999
  • A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study.  22:6-10. 1999
  • A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study..  22:III6-II10. 1999
  • Enhanced external counterpulsation in the management of patients with cardiovascular disease.  22:173-178. 1999
  • Management Strategies for a Better Outcome in Unstable Coronary Artery Disease.  21:314-322. 1998
  • Angiotensin-II-receptors: new targets for antihypertensive therapy..  20:3-6. 1997
  • Clinical outcomes according to time to treatment.  20:III11-III15. 1997
  • Dynamics of coronary thrombolysis and reocclusion.  20:III2-III5. 1997
  • Prehospital strategies to expedite myocardial salvage.  20:III16-III20. 1997
  • Reducing door-to-needle time: Treatment delay versus presentation delay.  20:III21-III25. 1997
  • The need for wider utilization of thrombolytic therapy.  20:III26-III31. 1997
  • Accelerated TPA for treatment of prosthetic valve thrombosis..  19:665-668. 1996
  • Transesophageal echocardiography in diagnosing cardioembolic stroke..  18:705-708. 1995
  • The role of prolonged thrombolytic infusions and transesophageal echocardiography in thrombosed prosthetic heart valves: case report and review of the literature..  18:679-684. 1995
  • The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography..  18:205-208. 1995
  • Authors' reply.  16:A22-A22. 1993
  • Panel discussion: Question and answer session.  16:30-31. 1993
  • Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators..  15:143-144. 1992
  • Thrombolytic therapy for myocardial infarction: A perspective of clinical trialists.  15:143-144. 1992
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments..  14:V29-V32. 1991
  • Mitral annular calcification and coarctation of aorta..  11:578-580. 1988
  • Clinical assessment of beta blockade..  11:311-316. 1988
  • Position as a variable for cardiovascular responses during exercise..  10:137-142. 1987
  • Prevalence of mitral valve prolapse in presumably healthy korean adults.  8:356-358. 1985
  • Hemoptysis following Mustard repair: a late complication..  7:673-677. 1984
  • Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization..  7:280-282. 1984
  • Serial ambulatory monitoring in patients with unstable angina pectoris.  6:435-439. 1983
  • Response to Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: Findings from Get With the Guidelines-Coronary Artery Diseases. Authors' reply..  37:323. 2014
  • SAFETY AND EFFICACY OF SONICATED ALBUMIN MICROSPHERES IN PERFUSION AND VEIN GRAFT PATENCY ASSESSMENTS 1991